Trump picks abortion foe Heidi Overton to lead FDA
President Trump has nominated Dr. Heidi Overton, a physician known for opposing abortion, to serve as commissioner of the Food and Drug Administration. The selection signals a potential shift in FDA policy, as the agency oversees the regulation of drugs including medication abortion. If confirmed by the Senate, Overton could influence access to abortion pills and broader public health regulations.
Sources (4)
Related stories
Shabana Mahmood outlines changes to settlement rules for legal migrants
UK minister Shabana Mahmood has set out proposed changes to the rules governing how legal migrants can settle in the country. The changes could affect eligibility and timelines for settlement, with significant implications for migrants and their families.
Marvell to acquire Lumentum for $115B in one of tech's largest deals
Marvell has agreed to buy Lumentum for $115 billion in one of the largest technology acquisitions ever. The deal would consolidate major semiconductor and optical networking players, with significant implications for data center and telecom supply chains. It is likely to face regulatory scrutiny.
NYT sues Brave over AI scraping and paywall bypass
The New York Times has sued Brave Software, alleging that its browser's AI features scrape NYT content and bypass paywalls. The case adds to growing legal fights over AI data use and publisher control. It could set a precedent for how browser-based AI tools handle paywalled news.
Fighting resumes in Kherson after Ukraine war's longest ceasefire
Fighting has returned to Ukraine's Kherson region after the longest ceasefire of the war, according to BBC World. The renewed clashes show that the recent pause in hostilities has collapsed, raising risks for civilians and frontline troops. Kherson remains strategically important because of its position on the Dnipro River and its role in the southern front.
Right-Wing Think Tank Plan Aims to Block Democrats From Congress
Wired reports that a right-wing think tank has developed a plan to prevent Democratic lawmakers from being seated in Congress. The proposal appears to target the congressional seating process, raising concerns about election certification and representation. If pursued, it could undermine democratic norms and the ability of voters to have their elected representatives seated.